The use of Medpor implants for midface contouring in cleft patients.

Medpor cleft facial implant malar midfacial hypoplasia nasal dorsum paranasal

Journal

International journal of oral and maxillofacial surgery
ISSN: 1399-0020
Titre abrégé: Int J Oral Maxillofac Surg
Pays: Denmark
ID NLM: 8605826

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 19 09 2018
accepted: 22 02 2019
pubmed: 16 3 2019
medline: 30 10 2019
entrez: 16 3 2019
Statut: ppublish

Résumé

Three-dimensional midfacial deficiency in cleft patients is common and is frequently connected to impairment of the aesthetic facial appearance. Different approaches to augment relevant facial regions are available. Alloplastic facial implants have been established as a viable alternative to autologous tissue augmentation in various circumstances. However, in cleft patients, the application of facial implants has rarely been reported. This retrospective study aimed to evaluate the use of Medpor implants for midfacial contouring in cleft patients. Fifty-one patients with orofacial clefts were assessed with regard to defined parameters. A range of Paranasal, Malar and Nasal Dorsum Medpor implants had been used. Unilateral cleft lip and palate (UCLP) represented the most common indication, followed by bilateral cleft lip and palate (BCLP). Bilateral implant insertion was performed as a general rule with few exceptions. Insertion of implants was frequently combined with other cleft-related surgical procedures. Even after orthognathic surgery, midfacial augmentation was implemented to specifically address residual volume deficiency, particularly in the malar region. The complication rate amounted to 4.9% (6/122 implants). Based on our findings, Medpor implants are reliable and long-term stable materials to successfully augment paranasal, subnasal and malar areas as well as a solid nasal dorsum material with few complications in cleft patients.

Identifiants

pubmed: 30871847
pii: S0901-5027(19)30090-6
doi: 10.1016/j.ijom.2019.02.008
pii:
doi:

Substances chimiques

Medpor 0
Polyethylenes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1177-1184

Informations de copyright

Copyright © 2019 International Association of Oral and Maxillofacial Surgeons. All rights reserved.

Auteurs

M Schwaiger (M)

South Thames Cleft Service, Guys and St. Thomas Hospital, London, UK. Electronic address: michael.schwaiger@medunigraz.at.

K Echlin (K)

South Thames Cleft Service, Guys and St. Thomas Hospital, London, UK.

D Atherton (D)

South Thames Cleft Service, Guys and St. Thomas Hospital, London, UK.

P Haers (P)

South Thames Cleft Service, Guys and St. Thomas Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH